AL
VYGR icon

AJO LP’s Voyager Therapeutics VYGR Stock Holding History

AJO LP’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,462
Closed -$118K – 760
2019
Q4 		$118K Buy
+8,462
New +$123K ﹤0.01% 533

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AJO LP's VYGR Position: Q1 2020 in Review

AJO LP sold out of Voyager Therapeutics (VYGR) in Q1 2020, closing a stake of 8,462 shares — an estimated $118K sold.

AJO LP first reported a position in VYGR in Q4 2019 and held it in 1 quarter. The position peaked at $118K in Q4 2019. 121 funds tracked by Wall St. Rank hold VYGR as of Q1 2020.

  • AJO LP reported no remaining Voyager Therapeutics position as of Q1 2020 after selling out during the quarter.
  • AJO LP sold 8,462 Voyager Therapeutics shares in Q1 2020, an estimated $118K.
  • AJO LP first reported a position in Voyager Therapeutics in Q4 2019 and held it in 1 quarter.
  • AJO LP's Voyager Therapeutics position peaked at $118K in Q4 2019.
  • 121 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2020.

Based on AJO LP's 13F filing for Q1 2020, filed 14 May 2020.